Ameesh Isath
@ameeshisath
Followers
2K
Following
2K
Statuses
1K
Adv HF and Transplant Fellow @BrighamWomens | Previously @nymedcollege, @DOMSinaiNYC| Interest in MCS, Transplant | ππ½ββοΈποΈ for the π«| Chelsea π
New York, USA
Joined February 2018
Always a fun time catching up with @SrihariNaiduMD! #WMCStrong Challenge accepted for LA ha. :)
Fun 24 hr trip to #THT2025 @crfheart they always put on a great show. Good to see so many HF docs discussing future & innovation incl our debate on DanGer which I truly enjoyed. Great seeing former fellows and new mentees. @dranulala we missed our pic π Back at work by noon!
1
1
8
RT @SrihariNaiduMD: Fun 24 hr trip to #THT2025 @crfheart they always put on a great show. Good to see so many HF docs discussing future & iβ¦
0
4
0
Sharing our editorial @TheJHLT discussing the limited yield of EMBx in the contemporary era. We propose "for-cause" biopsies; Non-invasive alternatives promising but with low PPV. Multimodal approaches + clinical assessment maybe the future.
0
0
9
Congratulations to the incredible team!! @SuguruOhira as always an amazing mentor behind this work! @ShazliKhanMD
π1 oral and 8 posters were accepted to @ISHLT meeting 2025 in Boston Congratulations @ShazliKhanMD @ameeshisath , Nate, Caroline, and @nymedcollege students @WMCCardsFellows @stephenpanmd @Transmedics @jjmt_heartrecov
0
3
9
0
0
1
RT @SuguruOhira: Extended use of axillary impella 5.5 as a bridge to ischemic VSD repair β¦@ameeshisathβ© β¦@VasilikiGregβ© β¦@jjmt_heartrecovβ©β¦
0
5
0
Is the next frontier in HF rooted in innate immune memory and bone marrow's role in co-morbidities? Time to revisit immune Rx based on novel mechanistic studies? We explore new insights into HF progression: ππ½ @MRMehraMD for the invaluable mentorship!
0
2
14
0
1
1
Thank you @SrihariNaiduMD for the opportunity to share our WMC experience on this complex case. These scenarios will likely become increasingly common, underscoring the need for multidisciplinary approaches and thoughtful patient-centered care!
What goes in must come out. And sometimes thatοΏ½οΏ½οΏ½s the end of the road. Great perspective on withdrawal of mechanical support as part of palliative care. An important new paradigm. β¬οΈ @ameeshisath @stephenpanmd @JCardFail @dranulala @jennifer_rymer @robmentz
0
1
4
Thank you @stephenpanmd! π΄πin Impella 5.5 used as BTT, raises complex end-of-life challenges π΄Thoughtful pt selection & multi-D care is π Rollercoaster of emotions taking care of our patient. Thanks to @SrihariNaiduMD & @JCardFail for opportunity to share our experience.
Shout out to former @WMCCardsFellows and now @BrighamWomens CHF fellow @ameeshisath for spearheading this perspective piece on multidisciplinary palliative care in those on #impella 5.5 support, now out in JCF. A tough topic but he did a stellar job!
0
0
4
RT @TanyaSh112: Presented our data from @CCCTNetwork regarding Younger patients in the CICU at @escardio as part of the best acute CV careβ¦
0
3
0
RT @SrihariNaiduMD: In 1 month we unveil special issue @JCardFail on interv heart failure! By @jennifer_rymer and me π 28 papers - 9 oriβ¦
0
21
0
@SrihariNaiduMD @JDawnAbbott1 @ElsevierConnect @SCAI @davebaran @stephenpanmd @purviparwani @docbhardwaj @ShelleyWood2 @WMCCardsFellows @thiele_holger @seanvandiepen @agtruesdell @HFSA @PerwaizMeraj @baileyannRN @mirvatalasnag @djc795 @CMichaelGibson @Abiomed @GreggWStone @SVRaoMD Excited to see this! Thank you so much for the opportunity!
1
1
2
RT @SuguruOhira: β¦@VasilikiGregβ© and β¦@ameeshisathβ© did a great job! published in β¦@ArtifOrgansβ© β¦@Transmedicsβ© β¦@WMCCardsFellowsβ© β¦@STS_Cβ¦
0
6
0
RT @SuguruOhira: Axillary access considerations in Impella 5.5Β insertion Read our article by β¦@ShazliKhanMDβ© β¦@ameeshisathβ© published in β¦@β¦
0
3
0
0
0
2
Excited to share our editorial on 1-yr ECMO-CS outcomes in @ESC_Journals @EJHFEiC! Insights from recent trials and the future of CS π΄ MAP threshold for MCS escalation π΄ Peripheral circulation π for the future Grateful to my mentor @MRMehraMD
0
0
10